Our Technologies
Preliminary diagnostic technology that responds quickly to albumin only
Development of biorthogonal click fluorescence probes
Platform technology that binds peptide drugs, molecular drugs, and protein drugs to albumin
Photodynamic therapy probe patents and technologies with superior cancer cell targeting abilities
"Identified potential for targeted drug for malignant triple-negative breast cancer"
"KYTECBIO confirms the effectiveness of drug delivery to cancer cells in animals"
Inquiry for Technology Alliances and Industrial Cooperation
KYTECBIO holds patents on compositions for
diagnosis and albumin-binding pharmaceuticals.
We welcome inquiries about related technology alliances and industry collaborations.
google-site-verification: googlebd2f6b3ca458b341.html
English 
한국어